Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers-Reference-Cited by-同舟云学术

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

Published:2021-08 Issue:2 Volume:83 Page:237-279
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Tré-Hardy Marie,Cupaiolo Roberto,Papleux Emmanuelle,Wilmet Alain,Horeanga Alexandra,Antoine-Moussiaux Thomas,Della Vecchia Andrea,Beukinga Ingrid,Vekemans Marc,Blairon Laurent

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers;Harris;J Infect,2021

2. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine;Krammer;N Engl J Med,2021

3. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals;Manisty;Lancet,2021

4. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody;Tré-Hardy;Clin Chem Lab Med,2020

5. Joint Committee on Vaccination and Immunisation. Optimising the COVID-19 vaccination programme for maximum short-term impact. 2021.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study;Vaccines;2024-02-26

2. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis;European Respiratory Review;2023-07-12

3. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review;BMC Infectious Diseases;2023-06-26

4. Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults;2023-04-11

5. Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study;BMJ Open;2023-03